Financhill
Back

AbbVie Quote, Financials, Valuation and Earnings

AbbVie Price Quote

$175.68
+0.10 (+2.43%)
(Updated: December 21, 2024 at 5:13 AM ET)

AbbVie Key Stats

Sell
40
AbbVie (ABBV) is a Sell

Day range:
$170.66 - $176.80
52-week range:
$153.09 - $207.32
Dividend yield:
3.53%
P/E ratio:
64.55
P/S ratio:
5.61
P/B ratio:
51.44%

Volume:
17.5M
Avg. volume:
7.6M
1-year change:
15.75%
Market cap:
$310.3B
Revenue:
$54.3B
EPS:
$2.88

How Much Does AbbVie Make?

Data Unavailable

Is AbbVie Growing As A Company?

Data Unavailable

AbbVie Stock Price Performance

  • Did AbbVie Stock Go Up Last Month?
    AbbVie share price went up by 4.66% last month
  • Did ABBV's Share Price Rise Over The Last Year?
    ABBV share price rose by 15.75% over the past 1 year

What Is AbbVie 52-Week High & Low?

  • What Is AbbVie’s 52-Week High Share Price?
    AbbVie has traded as high as $207.32 over the past 52 weeks
  • What Is AbbVie’s 52-Week Low Share Price?
    AbbVie has traded as low as $153.09 over the past 52 weeks

AbbVie Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AbbVie?

Data Unavailable

Is AbbVie Cash Flow Positive?

Data Unavailable

AbbVie Return On Invested Capital

Data Unavailable

AbbVie Earnings Date & Stock Price

  • What Is AbbVie's Stock Price Today?
    A single share of ABBV can be purchased today for 175.58
  • What Is AbbVie’s Stock Symbol?
    AbbVie trades on the S&P500 under the ticker symbol: ABBV
  • When Is AbbVie’s Next Earnings Date?
    The next quarterly earnings date for AbbVie is scheduled on January 31, 2025
  • When Is ABBV's next ex-dividend date?
    AbbVie's next ex-dividend date is January 15, 2025
  • How To Buy AbbVie Stock?
    You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AbbVie Competitors

  • Who Are AbbVie's Competitors?
    Below is a list of companies who compete with AbbVie or are related in some way:
    • Amgen Inc (AMGN)
    • Johnson & Johnson (JNJ)
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)

AbbVie Dividend Yield

Data Unavailable

AbbVie Analyst Estimates

YoY Growth Past Surprise
EPS: -12% 2.82%
Revenue: 3.83% 1.28%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 10
Sell Recommendations: 0
Price Target: 202.54
Upside from Last Price: 15.36%

Major Shareholders

Data Unavailable